Assyro AI

Orange Book product · Generic (ANDA)

BUTALBITAL, ASPIRIN AND CAFFEINE

ASPIRIN; BUTALBITAL; CAFFEINE

Generic (ANDA)ANDA 078149TE AARX MPP PHARMA

At a glance

Jun 13, 2007

Approved

Generic (ANDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 13, 2007

    19 yr 4 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ASPIRIN; BUTALBITAL; CAFFEINE

Strength

325MG;50MG;40MG

Dosage form

CAPSULE

Route

ORAL

TE code

AA

Application

ANDA 078149

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ASPIRIN; BUTALBITAL; CAFFEINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.